{
  "actions": [
    {
      "acted_at": "1973-03-06", 
      "committee": "House Committee on Interstate and Foreign Commerce", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to House Committee on Interstate and Foreign Commerce.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr5197-93", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Interstate and Foreign Commerce", 
      "committee_id": "HSIF"
    }
  ], 
  "congress": "93", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "1973-03-06", 
  "number": "5197", 
  "official_title": "A bill to amend the Controlled Substances Act to require identification by manufacturer of each schedule II dosage unit produced.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr5285-93", 
      "reason": "identical"
    }, 
    {
      "bill_id": "s984-93", 
      "reason": "identical"
    }
  ], 
  "short_title": "Dangerous Drug Identification Act", 
  "sponsor": {
    "district": "35", 
    "name": "Anderson, Glenn M.", 
    "state": "CA", 
    "thomas_id": "00016", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "1973-03-06", 
  "subjects": [
    "Consumer protection", 
    "Drug law and legislation", 
    "Drugs", 
    "Labeling"
  ], 
  "subjects_top_term": "Drug law and legislation", 
  "summary": {
    "as": "Introduced", 
    "date": "1973-03-06", 
    "text": "Dangerous Drug Identification Act - Requires that each solid oral form dosage unit carry a manufacturer's identification as required by regulation of the Attorney General."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Dangerous Drug Identification Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "A bill to amend the Controlled Substances Act to require identification by manufacturer of each schedule II dosage unit produced.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T18:17:15-05:00"
}